What is Achieve Life Sciences, Inc.'s Market Cap?

Achieve Life Sciences, Inc.'s Market Cap is $806.8M, based on as-reported figures from SEC (XBRL) filings.

What is Achieve Life Sciences, Inc.'s Enterprise Value?

Achieve Life Sciences, Inc.'s Enterprise Value is $619.5M, based on as-reported figures from SEC (XBRL) filings.

What is Achieve Life Sciences, Inc.'s Net Income (TTM)?

Achieve Life Sciences, Inc.'s Net Income (TTM) is -$114.0M, based on as-reported figures from SEC (XBRL) filings.

What is Achieve Life Sciences, Inc.'s Diluted EPS (TTM)?

Achieve Life Sciences, Inc.'s Diluted EPS (TTM) is -1.11, based on as-reported figures from SEC (XBRL) filings.

What is Achieve Life Sciences, Inc.'s Net Debt?

Achieve Life Sciences, Inc.'s Net Debt is -$187.3M, based on as-reported figures from SEC (XBRL) filings.

Achieve Life Sciences, Inc. (ACHV) Financial Statements

Achieve Life Sciences, Inc.

SIC 2835 · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

FIGI BBG001S8JF14

XNAS · usd

7.84▼ 0.65 (-7.66%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close8.49

Day's Range7.82 – 8.34

52-Week Range2.62 – 8.64

Volume3.5M

Avg Volume1.4M

Share Statistics

Shares Outstanding

Employees28

ExchangeXNAS

Listed1995-10-12

Share count as of August 11, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Achieve Life Sciences, Inc. (ACHV)

What is Achieve Life Sciences, Inc.'s Market Cap?: Achieve Life Sciences, Inc.'s Market Cap is $806.8M, based on as-reported figures from SEC (XBRL) filings.
What is Achieve Life Sciences, Inc.'s Enterprise Value?: Achieve Life Sciences, Inc.'s Enterprise Value is $619.5M, based on as-reported figures from SEC (XBRL) filings.
What is Achieve Life Sciences, Inc.'s Net Income (TTM)?: Achieve Life Sciences, Inc.'s Net Income (TTM) is -$114.0M, based on as-reported figures from SEC (XBRL) filings.
What is Achieve Life Sciences, Inc.'s Diluted EPS (TTM)?: Achieve Life Sciences, Inc.'s Diluted EPS (TTM) is -1.11, based on as-reported figures from SEC (XBRL) filings.
What is Achieve Life Sciences, Inc.'s Net Debt?: Achieve Life Sciences, Inc.'s Net Debt is -$187.3M, based on as-reported figures from SEC (XBRL) filings.